Drug Details
| General Information of the Drug (ID: DR2728) | ||||
|---|---|---|---|---|
| Name |
17-beta estradiol
|
|||
| Synonyms |
Ostradiol.Ostradiol; Beta Estradiol Anhydrate; SCHEMBL772341
Click to Show/Hide
|
|||
| Molecular Type |
Small molecule
|
|||
| Disease | Hepatocellular carcinoma [ICD-11: 2C12] | Investigative | [1] | |
| Structure |
|
Click to Download Mol2D MOL |
||
| Click to Show/Hide the Molecular Information and External Link(s) of This Natural Product | ||||
| Formula |
C36H48O4
|
|||
| PubChem CID | ||||
| Canonical SMILES |
CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O.CC12CCC3C(C1CCC2O)CCC4=C3C=CC(=C4)O
|
|||
| InChI |
1S/2C18H24O2/c2*1-18-9-8-14-13-5-3-12(19)10-11(13)2-4-15(14)16(18)6-7-17(18)20/h2*3,5,10,14-17,19-20H,2,4,6-9H2,1H3/t2*14-,15-,16+,17+,18+/m11/s1
|
|||
| InChIKey |
DWMXQLDCXDJLRZ-ZFOCPYFBSA-N
|
|||
| Combinatorial Therapeutic Effect(s) Validated Clinically or Experimentally | ||||||
|---|---|---|---|---|---|---|
| α. A List of Natural Product(s) Able to Decrease the Adverse Effect of This Drug | ||||||
| Genistein | Glycine max | Click to Show/Hide the Molecular Data of This NP | ||||
| Decreasing Adverse Drug Reaction | Click to Show/Hide | |||||
| Representative Experiment Reporting the Effect of This Combination | [2] | |||||
| Detail(s) |
Combination Info
click to show the detail info of this combination
|
|||||
| Molecule(s)
Regulation |
Up-regulation | Expression | COMT | Molecule Info |
Pathway MAP
|
|
| Up-regulation | Expression | CYP1A1 | Molecule Info |
Pathway MAP
|
||
| In-vitro Model | LNCaP | CVCL_0395 | Prostate carcinoma | Homo sapiens | ||
| PC-3 | CVCL_0035 | Prostate carcinoma | Homo sapiens | |||
| Experimental
Result(s) |
Genistein decreases the adverse effects of estrogen in LNCaP and PC-3 prostate cancer cells. | |||||
| Target and Pathway | ||||
|---|---|---|---|---|
| Target(s) | Nucleoside transporter 1 (SLC29A1) | Molecule Info | [3] | |
